List of Tables
Table 1. Global Neuromyelitis Optica Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Glucocorticoids
Table 3. Key Players of Immunotherapies
Table 4. Key Players of Others
Table 5. Global Neuromyelitis Optica Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Neuromyelitis Optica Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Neuromyelitis Optica Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Neuromyelitis Optica Drug Market Share by Region (2019-2024)
Table 9. Global Neuromyelitis Optica Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Neuromyelitis Optica Drug Market Share by Region (2025-2030)
Table 11. Neuromyelitis Optica Drug Market Trends
Table 12. Neuromyelitis Optica Drug Market Drivers
Table 13. Neuromyelitis Optica Drug Market Challenges
Table 14. Neuromyelitis Optica Drug Market Restraints
Table 15. Global Neuromyelitis Optica Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Neuromyelitis Optica Drug Revenue Share by Players (2019-2024)
Table 17. Global Top Neuromyelitis Optica Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Drug as of 2023)
Table 18. Global Neuromyelitis Optica Drug Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Neuromyelitis Optica Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Neuromyelitis Optica Drug, Headquarters and Area Served
Table 21. Global Key Players of Neuromyelitis Optica Drug, Product and Application
Table 22. Global Key Players of Neuromyelitis Optica Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Neuromyelitis Optica Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Neuromyelitis Optica Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Neuromyelitis Optica Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Neuromyelitis Optica Drug Revenue Share by Application (2019-2024)
Table 30. Global Neuromyelitis Optica Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Neuromyelitis Optica Drug Revenue Share by Application (2025-2030)
Table 32. North America Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Neuromyelitis Optica Drug Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Neuromyelitis Optica Drug Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Neuromyelitis Optica Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Neuromyelitis Optica Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Neuromyelitis Optica Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Neuromyelitis Optica Drug Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Neuromyelitis Optica Drug Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Neuromyelitis Optica Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Neuromyelitis Optica Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Neuromyelitis Optica Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Neuromyelitis Optica Drug Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Neuromyelitis Optica Drug Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Neuromyelitis Optica Drug Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Neuromyelitis Optica Drug Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Neuromyelitis Optica Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Neuromyelitis Optica Drug Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Neuromyelitis Optica Drug Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size by Country (2025-2030) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Neuromyelitis Optica Drug Product
Table 67. Pfizer Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Fresenius Company Details
Table 70. Fresenius Business Overview
Table 71. Fresenius Neuromyelitis Optica Drug Product
Table 72. Fresenius Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 73. Fresenius Recent Developments
Table 74. Teva Company Details
Table 75. Teva Business Overview
Table 76. Teva Neuromyelitis Optica Drug Product
Table 77. Teva Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 78. Teva Recent Developments
Table 79. Sandoz Company Details
Table 80. Sandoz Business Overview
Table 81. Sandoz Neuromyelitis Optica Drug Product
Table 82. Sandoz Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 83. Sandoz Recent Developments
Table 84. Intas Company Details
Table 85. Intas Business Overview
Table 86. Intas Neuromyelitis Optica Drug Product
Table 87. Intas Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 88. Intas Recent Developments
Table 89. Gyjtrs Company Details
Table 90. Gyjtrs Business Overview
Table 91. Gyjtrs Neuromyelitis Optica Drug Product
Table 92. Gyjtrs Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 93. Gyjtrs Recent Developments
Table 94. NANG KUANG Company Details
Table 95. NANG KUANG Business Overview
Table 96. NANG KUANG Neuromyelitis Optica Drug Product
Table 97. NANG KUANG Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 98. NANG KUANG Recent Developments
Table 99. Tianjin Kingyork Company Details
Table 100. Tianjin Kingyork Business Overview
Table 101. Tianjin Kingyork Neuromyelitis Optica Drug Product
Table 102. Tianjin Kingyork Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 103. Tianjin Kingyork Recent Developments
Table 104. Baxter Company Details
Table 105. Baxter Business Overview
Table 106. Baxter Neuromyelitis Optica Drug Product
Table 107. Baxter Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 108. Baxter Recent Developments
Table 109. CSL Company Details
Table 110. CSL Business Overview
Table 111. CSL Neuromyelitis Optica Drug Product
Table 112. CSL Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 113. CSL Recent Developments
Table 114. Grifols Company Details
Table 115. Grifols Business Overview
Table 116. Grifols Neuromyelitis Optica Drug Product
Table 117. Grifols Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 118. Grifols Recent Developments
Table 119. Octapharma Company Details
Table 120. Octapharma Business Overview
Table 121. Octapharma Neuromyelitis Optica Drug Product
Table 122. Octapharma Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 123. Octapharma Recent Developments
Table 124. CBOP Company Details
Table 125. CBOP Business Overview
Table 126. CBOP Neuromyelitis Optica Drug Product
Table 127. CBOP Revenue in Neuromyelitis Optica Drug Business (2019-2024) & (US$ Million)
Table 128. CBOP Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromyelitis Optica Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Neuromyelitis Optica Drug Market Share by Type: 2023 VS 2030
Figure 3. Glucocorticoids Features
Figure 4. Immunotherapies Features
Figure 5. Others Features
Figure 6. Global Neuromyelitis Optica Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Neuromyelitis Optica Drug Market Share by Application: 2023 VS 2030
Figure 8. Acute Attack Case Studies
Figure 9. Remission Prophylactic Treatment Case Studies
Figure 10. Neuromyelitis Optica Drug Report Years Considered
Figure 11. Global Neuromyelitis Optica Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Neuromyelitis Optica Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Neuromyelitis Optica Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Neuromyelitis Optica Drug Market Share by Players in 2023
Figure 15. Global Top Neuromyelitis Optica Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Drug Revenue in 2023
Figure 17. North America Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Neuromyelitis Optica Drug Market Share by Type (2019-2030)
Figure 19. North America Neuromyelitis Optica Drug Market Share by Application (2019-2030)
Figure 20. North America Neuromyelitis Optica Drug Market Share by Country (2019-2030)
Figure 21. United States Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Neuromyelitis Optica Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Neuromyelitis Optica Drug Market Share by Type (2019-2030)
Figure 25. Europe Neuromyelitis Optica Drug Market Share by Application (2019-2030)
Figure 26. Europe Neuromyelitis Optica Drug Market Share by Country (2019-2030)
Figure 27. Germany Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Neuromyelitis Optica Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Neuromyelitis Optica Drug Market Share by Type (2019-2030)
Figure 35. China Neuromyelitis Optica Drug Market Share by Application (2019-2030)
Figure 36. Asia Neuromyelitis Optica Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Neuromyelitis Optica Drug Market Share by Type (2019-2030)
Figure 38. Asia Neuromyelitis Optica Drug Market Share by Application (2019-2030)
Figure 39. Asia Neuromyelitis Optica Drug Market Share by Region (2019-2030)
Figure 40. Japan Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Neuromyelitis Optica Drug Market Share by Country (2019-2030)
Figure 50. Brazil Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Neuromyelitis Optica Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 57. Fresenius Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 58. Teva Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 59. Sandoz Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 60. Intas Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 61. Gyjtrs Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 62. NANG KUANG Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 63. Tianjin Kingyork Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 64. Baxter Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 65. CSL Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 66. Grifols Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 67. Octapharma Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 68. CBOP Revenue Growth Rate in Neuromyelitis Optica Drug Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed